Expression of p53 enhances selenite-induced superoxide production and apoptosis in human prostate cancer cells

Cancer Research

Volumn 66, Issue 4, 2006, Pages 2296-2304

  Zhao, Rui ^a   Xiang, Nong ^a   Domann, Frederick E ^c   Zhong, Weixiong ^a,b  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b WILLIAM S MIDDLETON MEMORIAL VETERANS HOSPITAL   (United States)

^c UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 9; CYCLIN DEPENDENT KINASE INHIBITOR 1; CYTOCHROME C; PROTEIN BAX; PROTEIN P53; REACTIVE OXYGEN METABOLITE; SELENITE; SELENIUM; SODIUM SELENITE; SUPEROXIDE;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CELL STRAIN LNCAP; CONTROLLED STUDY; CYTOSOL; DRUG EFFECT; DRUG MECHANISM; ENZYME ACTIVATION; HUMAN; HUMAN CELL; MALE; MITOCHONDRION; OXIDATION REDUCTION STATE; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RNA INTERFERENCE;

APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; CELL LINE, TUMOR; HUMANS; MALE; METALLOPORPHYRINS; MITOCHONDRIA; PROSTATIC NEOPLASMS; PROTEIN MODIFICATION, TRANSLATIONAL; SODIUM SELENITE; SUPEROXIDES; TUMOR SUPPRESSOR PROTEIN P53;

EID: 33644542078     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-05-2216     Document Type: Article

References (47)

1. Combs GF, Jr., Gray WP. Chemopreventive agents: selenium. Pharmacol Ther 1998;79:179-92.
2. Ganther HE. Selenium metabolism, selenoproteins and mechanisms of cancer prevention: complexities with thioredoxin reductase. Carcinogenesis 1999;20:1657-66.
3. Shamberger RJ, Tytko SA, Willis CE. Antioxidants and cancer. Part VI. Selenium and age-adjusted human cancer mortality. Arch Environ Health 1976;31:231-5.
4. Schrauzer GN, White DA, Schneider CJ. Cancer mortality correlation studies. III. Statistical association with dietary selenium intakes. Bioinorg Chem 1977;7:35-56.
5. Clark LC, Cantor KP, Allaway WH. Selenium in forage crops and cancer mortality in US counties. Arch Environ Health 1991;46:37-42.
6. Brooks JD, Metter EJ, Chow DW, et al. Plasma selenium level before diagnosis and the risk of prostate cancer development. J Urol 2001;166:2034-8.
7. Yoshizawa K, Willett WC, Morris SJ, et al. Study of prediagnostic selenium level in toenails and the risk of advanced prostate cancer. J Natl Cancer Inst 1998;90:1219-24.
8. Li HJ, Stampfer MJ, Giovannucci EL, et al. A prospective study of plasma selenium levels and prostate cancer risk. J Natl Cancer Inst 2004;96:696-703.
9. Clark LC, Combs GF, Jr., Turnbull BW, et al. Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. A randomized controlled trial. Nutritional Prevention of Cancer Study Group. J Am Med Assoc 1996;276:1957-63.
10. Klein EA, Thompson IM, Lippman SM, et al. SELECT: the next prostate cancer prevention trial. J Urol 2001;166:1311-5.
11. Combs GF. Status of selenium in prostate cancer prevention. Br J Cancer 2004;91:195-9.
12. Whanger PD. Selenium and its relationship to cancer: an update. Br J Nutr 2004;91:11-28.
13. Sinha R, El-Bayoumy K. Apoptosis is a critical cellular event in cancer chemoprevention and chemotherapy by selenium compounds. Curr Cancer Drug Targets 2004;4:13-28.
14. Seo YR, Kelley MR, Smith ML. Selenomethionine regulation of p53 by a ref1-dependent redox mechanism. Proc Natl Acad Sci U S A 2002;99:14548-53.
15. Zhong W, Oberley TD. Redox-mediated effects of selenium on apoptosis and cell cycle in the LNCaP human prostate cancer cell line. Cancer Res 2001;61:7071-8.
16. Park HS, Park E, Kim MS, et al. Selenite inhibits the c-Jun N-terminal kinase/stress-activated protein kinase (JNK/SAPK) through a thiol redox mechanism. J Biol Chem 2000;275:2527-31.
17. Powis G, Gasdaska JR, Gasdaska PY, et al. Selenium and the thioredoxin redox system: effects on cell growth and death. Oncol Res 1997;9:303-12.
18. Kim IY, Stadtman TC. Inhibition of NF-κB DNA binding and nitric oxide induction in human T cells and lung adenocarcinoma cells by selenite treatment. Proc Natl Acad Sci U S A 1997;94:12904-7.
19. Gopalakrishna R, Chen ZH, Gundimeda U. Seleno-compounds induce a redox modulation of protein kinase C in the cell, compartmentally independent from cytosolic glutathione: its role in inhibition of tumor promotion. Arch Biochem Biophys 1997;348:37-48.
20. McKenzie RC, Arthur JR, Beckett GJ. Selenium and the regulation of cell signaling, growth, and survival: molecular and mechanistic aspects. Antioxid Redox Signal 2002;4:339-51.
21. Spallholz JE. On the nature of selenium toxicity and carcinostatic activity. Free Radic Biol Med 1994;17:45-64.
22. Spallholz JE, Shriver BJ, Reid TW. Dimethyldiselenide and methylseleninic acid generate superoxide in an in vitro chemiluminescence assay in the presence of glutathione: implications for the anticarcinogenic activity of L-selenomethionine and L-Se-methylselenocysteine. Nutr Cancer 2001;40:34-41.
23. Shen H-M, Yang C-F, Ong C-N. Sodium selenite-induced oxidative stress and apoptosis in human hepatoma HepG2 cells. Int J Cancer 1999;81:820-8.
24. Jung U, Zheng X, Yoon SO, Chung AS. Se-methyl-selenocysteine induces apoptosis mediated by reactive oxygen species in HL-60 cells. Free Radic Biol Med 2001;31:479-89.
25. Kim TS, Yun BY, Kim IY. Induction of the mitochondrial permeability transition by selenium compounds mediated by oxidation of the protein thiol groups and generation of the superoxide. Biochem Pharmacol 2003;66:2301-11.
26. Zhong W, Yan T, Webber MM, et al. Alteration of cellular phenotype and responses to oxidative stress by manganese superoxide dismutase and a superoxide dismutase mimic in RWPE-2 human prostate adenocarcinoma cells. Antioxid Redox Signal 2004;6:513-22.
27. Lanfear J, Fleming J, Wu L, et al. The selenium metabolite selenodiglutathione induces p53 and apoptosis: relevance to the chemopreventive effects of selenium? Carcinogenesis 1994;15:1387-92.
28. Wei Y, Cao X, Qu Y, et al. SeO(2) induces apoptosis with down-regulation of Bcl-2 and upregulation of p53 expression in both immortal human hepatic cell line and hepatoma cell line. Mutat Res 2001;490:113-21.
29. Jiang C, Hu H, Malewicz B, et al. Selenite-induced p53 Ser-15 phosphorylation and caspase-mediated apoptosis in LNCaP human prostate cancer cells. Mol Cancer Ther 2004;3:877-84.
30. Li Y, Zhu H, Kuppusamy P, et al. Validation of lucigenin (bis-N-methylacridinium) as a chemilumigenic probe for detecting superoxide anion radical production by enzymatic and cellular systems. J Biol Chem 1998;273:2015-23.
31. Zhou N, Xiao H, Li TK, et al. DNA damage-mediated apoptosis induced by selenium compounds. J Biol Chem 2003;278:29532-7.
32. Garberg P, Stahl A, Warholm M, et al. Studies of the role of DNA fragmentation in selenium toxicity. Biochem Pharmacol 1988;37:3401-6.
33. Jiang C, Wang Z, Ganther H, et al. Caspases as key executors of methyl selenium-induced apoptosis (anoikis) of DU-145 prostate cancer cells. Cancer Res 2001;61:3062-70.
34. Rogakou EP, Pilch DR, Orr AH, et al. DNA double-stranded breaks induce histone H2AX phosphorylation on serine 139. J Biol Chem 1998;273:5858-68.
35. Chaudiere J, Courtin O, Leclaire J. Glutathione oxidase activity of selenocystamine: a mechanistic study. Arch Biochem Biophys 1992;296:328-36.
36. Vousden KH, Lu X. Live or let die: the cell's response to p53. Nat Rev Cancer 2002;2:594-604.
37. Hofseth LJ, Hussain SP, Harris CC. p53: 25 years after its discovery. Trends Pharmacol Sci 2004;25:177-81.
38. Burns TF, El-Deiry WS. The p53 pathway and apoptosis. J Cell Physiol 1999;181:231-9.
39. Marchenko ND, Zaika A, Moll UM. Death signal-induced localization of p53 protein to mitochondria. A potential role in apoptotic signaling. J Biol Chem 2000;275:16202-12.
40. Johnson TM, Yu ZX, Ferrans VJ, et al. Reactive oxygen species are downstream mediators of p53-dependent apoptosis. Proc Natl Acad Sci U S A 1996;93:11848-52.
41. Polyak K, Xia Y, Zweier JL, et al. A model for p53-induced apoptosis. Nature 1997;389:300-5.
42. Macip S, Igarashi M, Berggren P, et al. Influence of Induced Reactive Oxygen Species in p53-Mediated Cell Fate Decisions. Mol Cell Biol 2003;23:8576-85.
43. Kroemer G, Zamzami N, Susin SA. Mitochondrial control of apoptosis. Immunol Today 1997;18:44-51.
44. Li PF, Dietz R, von Harsdorf R. p53 regulates mitochondrial membrane potential through reactive oxygen species and induces cytochrome c-independent apoptosis blocked by Bcl-2. EMBO J 1999;18:6027-36.
45. Chandel NS, Vander Heiden MG, Thompson CB, et al. Redox regulation of p53 during hypoxia. Oncogene 2000;19:3840-8.
46. Bode AM, Dong Z. Post-translational modification of p53 in tumorigenesis. Nat Rev Cancer 2004;4:793-805.
47. Miyashita T, Reed JC. Tumor suppressor p53 is a direct transcriptional activator of the human Bax gene. Cell 1995;80:293-9.